Repare Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$1,073
$52,404
$13,047
Gross Profit
585
51,903
12,541
EBITDA
-36,818
11,317
-30,361
EBIT
-37,306
10,816
-30,867
Net Income
-34,774
13,162
-28,030
Net Change In Cash
1,073
52,404
13,047
Free Cash Flow
-30,514
11,932
-28,554
Cash
79,820
103,217
111,268
Basic Shares
42,445
44,024
42,139

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$51,133
$131,830
$7,600
$135
Gross Profit
-80,070
127,646
4,256
-1,652
EBITDA
-114,273
-17,818
-107,189
-53,405
EBIT
-116,224
-22,002
-110,533
-55,192
Net Income
-93,796
-29,047
-106,908
-53,417
Net Change In Cash
51,133
131,830
7,600
135
Cost of Revenue
8,085
231,995
Free Cash Flow
-129,096
-280
-87,486
-8,321
Cash
111,268
159,521
334,427
326,184
Basic Shares
42,093
41,922
37,818
36,902

Earnings Calls

Quarter EPS
2024-09-30
-$0.77
2024-06-30
-$0.82
2024-03-31
$0.30
2023-12-31
-$0.67